Praxis Medica
Sign in
Issue image

More articles from Volume 37, Issue 2, 2009

FUNCTIONAL ASYMMETRY OF BRAIN AND POTENTIALS P300

INFLUENCE OF DOXORUBICIN ON ELECTRICAL ACTIVITY OF THE MYOCARDIUM AND LEFT VENTRICULAR FUNCTION DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

MORPHOMETRIC AND STEREOLOGICAL ANALYSIS GANGLION STRUCTURES OF MYENTERIC NERVE PLEXUS, TERMINALLY PART OF HUMAN LARGE INTESTINE

MASSIVENESS OF A SICKNESS, A PATHOGENIC OF CONTAGIUM AND HENLE-KOCH POSTULATES

SOME ASPECTS OF FAMILY PLANNING - FROM MISCARRIAGE TO HEALTH EDUCATION

INFLUENCE OF DOXORUBICIN ON ELECTRICAL ACTIVITY OF THE MYOCARDIUM AND LEFT VENTRICULAR FUNCTION DURING TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

J. kolarović ,
J. kolarović

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
N. Konstantinidis ,
N. Konstantinidis

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
Lj. Milić-Georgijević ,
Lj. Milić-Georgijević

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
N. Kaćanski ,
N. Kaćanski

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar
G. Novović
G. Novović

Institute for Child and Youth Health Care of Vojvodina , Novi Sad , Serbia

View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2009.

Volume 37, Issue 2 (2009)

pp. 9-12;

https://doi.org/10.70949/pramed200902288K

Abstract

Doxorubicin is the most frequently used anthracycline antibiotic that expresses significant toxicity. Among all side  effects, hematological are the most common, while cardiac side effects are the most serious and the most important. The aim of this study was to investigate whether doxorubicin containing combined chemotherapy used in treatment of childhood acute lymphoblastic leukemia (ALL), influences electrical activity of the myocardium and left ventricular function in affected children. Experimental group consisted of 20 children with newly diagnosed ALL treated according to protocol YU ALL 95, while the control group consisted of 20 healthy children. Electrocardiograms (ECG) at rest were taken and analyzed, and corrected QT intervals (QTc) calculated. All children had echocardiograms (ECHO) including fractional shortening (FS) and ejection fraction (EF). Electrocardiograms, FS and EF were normal in all subjects, and were similar in both groups.

Keywords

doxorubicin,

children,

electrocardiogram,

fractional shortening,

ejection fraction

References

1.
Sallan SE, Clavel LA. Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: A 10-year experience. Sem Oncol. 11:19–21.
2.
Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst. 99:206–14.
3.
Schrappe M. Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial therapy: Results of trial ALL-BMF 90. Blood. 95:3310–5.
4.
Cvetkoviæ P. Standardi za praæenja bolesnika sa terapijom antraciklinima. Bilt Hematol. 23(3):156–8.
5.
Pudil R, Horacek JM, Strasova SA. Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines. Exp Oncol. 30:160–2.
6.
Isner JM, Ferrans VJ, Cohen. Clinical and morphological cardiac findings after anthracycline chemotherapy. Am J Cardiol. 51:1167–74.
7.
Bucsenez D, Bernuth G. The QT interval during exercise in healthy children 6-14 years old. J Electrocardiol. 22(1):17–9.
8.
Schwartz CL, Hobbie WL, Truesdell SC, Constine LS, Clark EB. QTc prolongation in anthracycline-treated survivors of childhood cancer. Proc Am Soc Clin Oncol. 9(22).
9.
Bender KS, Shematck JP, Leventhal BG, Kan JS. QT interval prolongation associated with anthracycline cardiotoxicity. J Pediatr. 106:442–4.
10.
Schwartz PJ, Periti M, Malliami A. The long QT syndrome. Am Heart J. 89:378–0.
11.
Salmon SE, Sartorelli AC. Cancer Chemotherapy. In: Basic & Clinical Pharmacology. p. 881–915.
12.
Ribera JM, Oriol A. Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am. 23(5):1033–42.
13.
Horacek JM, Jakl M, Horackova J, Pudl R, Jebavy L, Maly J. Assessment of anthracycline-induced cardiotoxicity with electrocardiography. Exp Oncol. 31(2):115–7.
14.
Gilladoga AC, Manuel C, Tan CTC, Wollner N, Sternberg SS, Murphy ML. The cardiotoxicity of Adriamycin and daunomycin in children. Cancer. 37:1070–8.
15.
Konstantinidis N. Evaluacija faktora rizika i primenjene terapije kod akutnih leukemija deèjeg uzrasta. In: Doktorska disertacija.
16.
Schwartz CL, Truesdell SC, Clark EB. The use of the corrected QT interval (QTc) in screening for anthracycline-related cardiotoxicity. In: Cardiac Toxicity After Treatment for Childhood Cancer. p. 103–8.
17.
Cvetkoviæ P, Stojimiroviæ E, Janiæ D. Treatment of acute lymphoblastic leukemia: The results of YU 0184 and 0187 protocols. Bilt Hematol. 23(1–2):43–6.
18.
Tukenova M, Guibout C, Oberlin O, Doyon F, Moussanif A, Haddy N, et al. Long-term overall and cardiovascular mortality following childhood cancer: The role of cancer treatment. J Clin Oncol. 28:1308–15.
19.
Iarussi D, Indolfi P, Casale F, Martino V, Tullio MT, Calabro R. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Paediatr Drugs. 7:67–76.
20.
Abraham R, Basser RL, Green MD. A risk - benefit assessment of anthracycline antibiotics in antineoplastic therapy. Drug Saf. 15:406–29.
21.
Lipshultz SE, Adams JM. Cardiotoxicity after childhood cancer: beginning with the end in mind. J Clin Oncol. 28:1276–81.
22.
Pui CH, Campana D, Pei D. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 360(26):2730–41.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref